PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms|Prostate Neoplasms|Neoplasms, Squamous Cell|Melanoma|Mesothelioma|Pancreatic Neoplasms|Colorectal Neoplasms|Carcinoma, Renal Cell|Liver Neoplasms
Interventions: DRUG: PF-06952229|DRUG: Enzalutamide
Sponsor: Pfizer